|
The global lung cancer surgery market size was USD 5.72 Billion in 2021 and is expected to register a revenue CAGR of 2.8% during the forecast period, according to latest analysis by Emergen Research. Increasing prevalence of lung cancer due to sedentary lifestyle is a major factor driving market revenue growth. The most common cancer that results in mortality globally is lung cancer. In the U.S., an estimated 236,740 people were diagnosed with lung cancer in 2022. 3.08 million middle and high school children use at least one tobacco product, including e-cigarettes, while almost 40 million American adults still smoke cigarettes. The U.S. spends about USD 225 billion annually on medical treatment to cure diseases brought on by adult smoking. The report is formulated with the updated and latest information of the global Lung Cancer Surgery market further validated and verified by the industry experts and professionals. The Global Lung Cancer Surgery Market report contains historical, current, and forecast estimation of the revenue generation and profits for each segment and sub-segment of the Lung Cancer Surgery market in each key region of the world. The report additionally sheds light on the emerging growth opportunities in the business sphere that are anticipated to bolster the growth of the market. Competitive Terrain: The global Lung Cancer Surgery industry is highly consolidated owing to the presence of renowned companies operating across several international and local segments of the market. These players dominate the industry in terms of their strong geographical reach and a large number of production facilities. The companies are intensely competitive against one another and excel in their individual technological capabilities, as well as product development, innovation, and product pricing strategies. The leading market contenders listed in the report are: Accuray Incorporated, General Electric Company, Johnson and Johnson Services, Inc., Siemens Healthcare GmbH, Olympus Corporation, Teleflex Incorporated, B. Braun SE, Medtronic plc, AngioDynamics, Inc., and FUJIFILM Holdings Corporation Key market aspects studied in the report: Market Scope: The report explains the scope of various commercial possibilities in the global Lung Cancer Surgery market over the upcoming years. The estimated revenue build-up over the forecast years has been included in the report. The report analyzes the key market segments and sub-segments and provides deep insights into the market to assist readers with the formulation of lucrative strategies for business expansion. Competitive Outlook: The leading companies operating in the Lung Cancer Surgery market have been enumerated in this report. This section of the report lays emphasis on the geographical reach and production facilities of these companies. To get ahead of their rivals, the leading players are focusing more on offering products at competitive prices, according to our analysts. Report Objective: The primary objective of this report is to provide the manufacturers, distributors, suppliers, and buyers engaged in this sector with access to a deeper and improved understanding of the global Lung Cancer Surgery market. Market Segmentations of the Lung Cancer Surgery Market This market is segmented based on Types, Applications, and Regions. The growth of each segment provides accurate forecasts related to production and sales by Types and Applications, in terms of volume and value for the period between 2022 and 2030. This analysis can help readers looking to expand their business by targeting emerging and niche markets. Market share data is given on both global and regional levels. Regions covered in the report are North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Research analysts assess the market positions of the leading competitors and provide competitive analysis for each company. For this study, this report segments the global Lung Cancer Surgery market on the basis of product, application, and region: Segments Covered in this report are: - Device Outlook (Revenue, USD Billion; 2019-2030)
- Surgical Instruments
- Monitoring Devices
- Endoscopic Instruments
- Surgery Type Outlook (Revenue, USD Billion; 2019-2030)
- Thoracotomy
- Minimally Invasive Surgeries
- End-Use Outlook (Revenue, USD Billion; 2019-2030)
- Cancer Hospitals
- Ambulatory Surgical Centers
Major Geographies Analyzed in the Report: - North America (U.S., Canada)
- Europe (U.K., Italy, Germany, France, Rest of EU)
- Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
- Latin America (Chile, Brazil, Argentina, Rest of Latin America)
- Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)
ToC of the report: Chapter 1: Market overview and scope Chapter 2: Market outlook Chapter 3: Impact analysis of COVID-19 pandemic Chapter 4: Competitive Landscape Chapter 5: Drivers, Constraints, Opportunities, Limitations Chapter 6: Key manufacturers of the industry Chapter 7: Regional analysis Chapter 8: Market segmentation based on type applications Chapter 9: Current and Future Trends Latest Published Reports by Emergen Research:
| 
Post time 2024-5-10 15:03:36
Favorites